1. Home
  2. JAMF vs AGIO Comparison

JAMF vs AGIO Comparison

Compare JAMF & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAMF
  • AGIO
  • Stock Information
  • Founded
  • JAMF 2002
  • AGIO 2007
  • Country
  • JAMF United States
  • AGIO United States
  • Employees
  • JAMF N/A
  • AGIO N/A
  • Industry
  • JAMF Computer Software: Prepackaged Software
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAMF Technology
  • AGIO Health Care
  • Exchange
  • JAMF Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • JAMF 1.9B
  • AGIO 2.0B
  • IPO Year
  • JAMF 2020
  • AGIO 2013
  • Fundamental
  • Price
  • JAMF $12.42
  • AGIO $30.28
  • Analyst Decision
  • JAMF Buy
  • AGIO Buy
  • Analyst Count
  • JAMF 9
  • AGIO 8
  • Target Price
  • JAMF $20.78
  • AGIO $56.57
  • AVG Volume (30 Days)
  • JAMF 812.1K
  • AGIO 637.9K
  • Earning Date
  • JAMF 05-07-2025
  • AGIO 05-01-2025
  • Dividend Yield
  • JAMF N/A
  • AGIO N/A
  • EPS Growth
  • JAMF N/A
  • AGIO N/A
  • EPS
  • JAMF N/A
  • AGIO 11.64
  • Revenue
  • JAMF $627,399,000.00
  • AGIO $36,498,000.00
  • Revenue This Year
  • JAMF $11.38
  • AGIO $50.61
  • Revenue Next Year
  • JAMF $12.58
  • AGIO $223.79
  • P/E Ratio
  • JAMF N/A
  • AGIO $2.61
  • Revenue Growth
  • JAMF 11.92
  • AGIO 36.07
  • 52 Week Low
  • JAMF $12.35
  • AGIO $27.14
  • 52 Week High
  • JAMF $21.41
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • JAMF 30.56
  • AGIO 39.54
  • Support Level
  • JAMF $12.96
  • AGIO $30.00
  • Resistance Level
  • JAMF $13.56
  • AGIO $32.90
  • Average True Range (ATR)
  • JAMF 0.37
  • AGIO 1.22
  • MACD
  • JAMF -0.02
  • AGIO -0.08
  • Stochastic Oscillator
  • JAMF 5.28
  • AGIO 9.12

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: